Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 78.46B P/E 50.78 EPS this Y 6.80% Ern Qtrly Grth 16.70%
Income 1.36B Forward P/E 20.09 EPS next Y 9.40% 50D Avg Chg 7.00%
Sales 19.72B PEG 2.08 EPS past 5Y 1.37% 200D Avg Chg 11.00%
Dividend 1.00% Price/Book 3.05 EPS next 5Y 8.60% 52W High Chg -4.00%
Recommedations 1.90 Quick Ratio 0.78 Shares Outstanding 289.01M 52W Low Chg 28.00%
Insider Own 0.31% ROA 3.20% Shares Float 288.34M Beta 0.44
Inst Own 88.06% ROE 5.37% Shares Shorted/Prior 2.16M/1.97M Price 276.24
Gross Margin 44.56% Profit Margin 6.76% Avg. Volume 1,216,300 Target Price 275.33
Oper. Margin 16.43% Earnings Date May 2 Volume 1,396,333 Change -0.83%
About Becton, Dickinson and Company

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company operates in three segments: BD Medical, BD Life Sciences, and BD Interventional. The BD Medical segment provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular access technology, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication safety and infusion therapy delivery systems, medication compounding workflow systems, automated medication dispensing and supply management systems, and medication inventory optimization and tracking systems; and prefillable drug delivery systems. The BD Life Sciences segment offers specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent systems, and solutions for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. The BD Interventional segment provides hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention; peripheral intervention products; and urology and critical care products. The company was founded in 1897 and is headquartered in Franklin Lakes, New Jersey.

Becton, Dickinson and Company News
07/25/24 BD, Quest Diagnostics Join Forces to Develop Companion Diagnostics for Cancer, Other Diseases
07/24/24 Reasons to Add The Cooper Companies (COO) to Your Portfolio Now
07/23/24 BD Board Declares Dividend
07/23/24 What Makes Becton Dickinson (BDX) a New Buy Stock
07/23/24 BDX vs. MMSI: Which Stock Should Value Investors Buy Now?
07/19/24 Here’s Why Madison Investors Fund Sold Becton, Dickinson and Company (BDX)
07/16/24 BD (BDX) Up on Efforts to Tackle Blood Culture Vial Shortage
07/11/24 3 Healthcare Stocks to Buy Now to Profit From Aging Population Trends
07/10/24 BD Statement on Supplier Issue Impacting BD BACTEC™ Blood Culture Vials
07/10/24 BD Surpasses Scope 1 and 2 Reduction Milestones for FY 2023
07/05/24 Three Reasons to Hold BD (BDX) Stock in Your Portfolio Now
07/04/24 BD to axe 200 jobs with Drogheda plant closure in Ireland
07/03/24 BD to Announce Financial Results for its Third Quarter of Fiscal 2024
07/01/24 Boing! 7 Undervalued Stocks That Could Surprise the Skeptics.
06/27/24 BD's (BDX) New Research Tool to Aid Single-Cell Analysis
05:45 AM New BD Research Tool Helps Scientists Study Cells that are Often Key Culprits in the Development of Cancer and Infectious Diseases
06/20/24 BD Announces Dates for Third Quarter and Fourth Quarter Fiscal 2024 Earnings Webcasts
06/10/24 Becton Dickinson & Co's Dividend Analysis
06/06/24 Is Becton, Dickinson and Company (NYSE:BDX) a Fairly Valued Dividend Aristocrat Stock?
06/05/24 BD (BDX) Inks Buyout Deal to Expand Smart Connected Care Suite
BDX Chatroom

User Image Pitbowl Posted - 54 minutes ago

$BDX $MRMD - Cannabis Icecream $BMY $CERN $CI https://www.youtube.com/shorts/KsYYrvMNybc

User Image Stocksrunner Posted - 1 day ago

Thursday After-Hours: Key Stocks Break Above 200-Day Moving Average $BDX $BGNE $CMCO $KNX $XEL have all crossed above their 200-day moving averages in today's trading session. This is a significant technical event that often signals a potential shift in long-term trend. The 200-day MA is a key indicator watched by many institutional investors and traders. While this doesn't guarantee future performance, it's generally seen as a bullish signal. https://stocksrunner.com/technical

User Image Aigner_Andreas Posted - 1 day ago

TD SELL $BDX at 237.34, Supp 221.47 Resis 237.34 R7 HiLo 27% T1Y 278 buy 2.4 DIV 1.51% #Becton Dic #stocks #trading #finance #market

User Image amberajax2point0 Posted - 3 days ago

$BDX dog 🐕 finally waking up, pushing one month highs…

User Image DaScientist Posted - 1 week ago

$BDX follow MSFT and lay off all DEI positions asap

User Image JohnDinosaur Posted - 1 week ago

$BDX oversold

User Image friendlyinvestor Posted - 2 weeks ago

$BDX started small position here

User Image friendlyinvestor Posted - 2 weeks ago

$BDX what happened here? Any chance this gonna reverse here

User Image Stock_Titan Posted - 2 weeks ago

$BDX BD Statement on Supplier Issue Impacting BD BACTEC™ Blood Culture Vials https://www.stocktitan.net/news/BDX/bd-statement-on-supplier-issue-impacting-bd-bactec-blood-culture-mp0lx81m3mkm.html

User Image Stock_Titan Posted - 2 weeks ago

$BDX BD Surpasses Scope 1 and 2 Reduction Milestones for FY 2023 https://www.stocktitan.net/news/BDX/bd-surpasses-scope-1-and-2-reduction-milestones-for-fy-kh2sxws7l1xw.html

User Image supersleezy Posted - 2 weeks ago

$BDX 52 wk low, hope it doesn’t break support.

User Image Stock_Titan Posted - 3 weeks ago

$BDX BD to Announce Financial Results for its Third Quarter of Fiscal 2024 https://www.stocktitan.net/news/BDX/bd-to-announce-financial-results-for-its-third-quarter-of-fiscal-vcbn35wjtxr8.html

User Image DonCorleone77 Posted - 3 weeks ago

$BDX Becton Dickinson added to 'Tactical Outperform' list, target trimmed at Evercore Evercore ISI lowered the firm's price target on Becton Dickinson to $285 from $290 and keeps an Outperform rating on the shares and is adding the stock to the firm's "Tactical Outperform" list ahead of earnings. In an earnings preview for the MedTech, Life Science Tools and Diagnostics group, the firm calls Becton Dickinson "one of the few stocks" with a reasonable valuation and revenue growth set to accelerate. Shares should re-rate if managment reaffirms 9% organic growth expectations for Q4, the analyst tells investors.

User Image YouOnlyLiveTwice Posted - 3 weeks ago

$BDX what rotation? You’re seeing big $$ going into tech today. If you’re not involved in AI your stock will continue to get sold off

User Image zztopps Posted - 06/28/24

$BDX This has been spinning its wheels for way too long, lagging all averages for quite some time. Perhaps it's going take a rotation out of tech into healthcare and other defensive issues to right the ship. The potential is here, management needs to execute.

User Image 11thestate Posted - 1 month ago

$BDX settled for $85M with investors to end litigation over software errors with Alaris infusion pumps. The claim deadline has already passed but you can file a late claim: https://11thestate.com/cases/bdx-shareholder-settlement Who is eligible: Anyone who bought BD stock or call options, or sold BD put options, from November 5, 2019, to February 5, 2020.

User Image Stock_Titan Posted - 1 month ago

$BDX New BD Research Tool Helps Scientists Study Cells that are Often Key Culprits in the Development of Cancer and Infectious Diseases https://www.stocktitan.net/news/BDX/new-bd-research-tool-helps-scientists-study-cells-that-are-often-key-blfly4btqdag.html

User Image Stock_Titan Posted - 1 month ago

$BDX BD Announces Dates for Third Quarter and Fourth Quarter Fiscal 2024 Earnings Webcasts https://www.stocktitan.net/news/BDX/bd-announces-dates-for-third-quarter-and-fourth-quarter-fiscal-2024-ierevh660rws.html

User Image QuiverQuant Posted - 1 month ago

CONGRESSIONAL TRADING: Representative Thomas H. Kean Jr. disclosed a purchase of $1,001 - $15,000 of $BDX on 2024-06-18.

User Image QuiverQuant Posted - 1 month ago

CONGRESSIONAL TRADING: Representative Thomas H. Kean Jr. disclosed a purchase of $1,001 - $15,000 of $BDX on 2024-06-18.

User Image MakingMeMeoutofME Posted - 1 month ago

$MLSS short position has come down to 386,000 from 415,000 CEO has been talking very positively on the last two conf calls. Imagine company starts to deliver a series of big wins along with singles and doubles. It's a game changer to the replacement of the syringe in many applications for the future. $BDX should and could eye them up in 2025

User Image 11thestate Posted - 1 month ago

$BDX agreed to pay $85M to investors to settle claims about software errors with Alaris infusion pumps. The claim deadline is today, so you can file for the payment here: https://11thestate.com/cases/bdx-shareholder-settlement Who is eligible:”All persons and entities who purchased or otherwise acquired BD common stock or call options, or sold BD put options, from November 5, 2019 to February 5, 2020, inclusive.”

User Image InsiderPeek Posted - 1 month ago

$BDX Chief Acct Officer Spoerel Thomas J sold 300 shares for $71.8k (ownership down 12.54%) insiderpeek.com/company/BDX

User Image JackDarwin Posted - 1 month ago

$BDX Nice Bullish Engulfing Pattern Formed.

User Image ItsAllAboutBeingFirst Posted - 1 month ago

$OBIO man is medtech M&A hot hot hot https://www.medtechdive.com/news/stryker-buys-artelon-soft-tissue-zimmer/717893/ $SYK $OBIO $BDX $SSNLF $JNJ Stryker / Becton / Samsung / J&J - all inking deals this year

User Image Roosterscanfly Posted - 1 month ago

$CTNT bring the volume, this will rise in a heartbeat with it. Look at the last month of history 😉😊✌❤ $ASTI $HOLO $SBFM $BDX

User Image 11thestate Posted - 1 month ago

The deadline for getting payment in the $BDX settlement is in two weeks. This settlement resolves claims over software errors with Alaris infusion pumps. To check the details and file for the payment: https://11thestate.com/cases/bdx-shareholder-settlement

User Image ShortingTheTrend Posted - 1 month ago

$BDX to Acquire $EW for $4.2 Billion in Cash

User Image ItsAllAboutBeingFirst Posted - 1 month ago

$ATRI $MDWD $OBIO $BDX another huge move in medtech today https://www.reuters.com/business/healthcare-pharmaceuticals/edwards-lifesciences-sell-critical-care-products-unit-becton-dickinson-42-bln-2024-06-03/

User Image briefingcom Posted - 1 month ago

$BDX: Becton Dickinson to acquire Edwards Lifesciences' $EW Critical Care Product Group for $4.2 billion https://www.briefing.com/in-depth-analysis/content/article?ArticleId=IN20240603063316BDX&utm_campaign=inplay&utm_medium=social&utm_source=st&utm_content=view_page

Analyst Ratings
Stifel Buy Jul 26, 24
Citigroup Neutral Jul 10, 24
Evercore ISI Group Outperform Jul 2, 24
Goldman Sachs Buy May 30, 24
Barclays Overweight May 6, 24
Barclays Overweight Feb 5, 24
Raymond James Outperform Jan 3, 24
Morgan Stanley Overweight Dec 4, 23
Piper Sandler Overweight Nov 10, 23
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Byrd Richard EVP & President Inte.. EVP & President Interventional Nov 28 Sell 238.47 2,156 514,141 4,120 11/29/23
Byrd Richard EVP & President Inte.. EVP & President Interventional Sep 05 Sell 274.48 459 125,986 3,444 09/06/23
Fraser Claire Director Director Aug 28 Sell 281.66 848 238,848 21,608 08/30/23
Garrison Michael David EVP & President Medi.. EVP & President Medical Aug 08 Sell 277.13 1,300 360,269 5,157 08/09/23
Goette Roland EVP and President, E.. EVP and President, EMEA Nov 16 Option 74.94 4,617 345,998 14,896 11/18/22
Hickey David EVP & President, Lif.. EVP & President, Life Sciences Aug 15 Sell 265.00 475 125,875 3,331 08/17/22
Polen Thomas E Jr Chairman, CEO and Pr.. Chairman, CEO and President Aug 15 Option 167.91 15,000 2,518,650 43,878 08/17/22
Polen Thomas E Jr Chairman, CEO and Pr.. Chairman, CEO and President Aug 15 Sell 265.13 9,500 2,518,735 28,878 08/17/22
Spoerel Thomas J VP Controller & Chie.. VP Controller & Chief Acct Off Jun 07 Sell 260 443 115,180 1,058 06/09/22
Spoerel Thomas J VP Controller & Chie.. VP Controller & Chief Acct Off Jun 07 Option 147.68 1,026 151,520 2,070 06/09/22
Hickey David EVP & President, Lif.. EVP & President, Life Sciences May 06 Sell 256 475 121,600 3,806 05/10/22
Larson Betty D EVP HR & CHRO EVP HR & CHRO Feb 25 Option 193.09 46,658 9,009,193 9,556 02/28/22
Larson Betty D EVP HR & CHRO EVP HR & CHRO Feb 25 Sell 271.9 14,374 3,908,291 5,872 02/28/22
Fraser Claire Director Director Feb 08 Sell 271.70 841 228,500 21,556 02/10/22
Conroy Alexandre EVP of Integrated Su.. EVP of Integrated Supply Chain Feb 03 Option 134.73 12,787 1,722,793 34,047 02/07/22
Conroy Alexandre EVP of Integrated Su.. EVP of Integrated Supply Chain Feb 03 Sell 270.16 6,410 1,731,726 21,260 02/07/22
Lim James C Executive Vice Presi.. Executive Vice President Sep 07 Sell 257.44 6,956 1,790,753 19,768 09/07/21
Lim James C Executive Vice Presi.. Executive Vice President Sep 07 Option 134.73 14,584 1,964,902 34,352 09/07/21